Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Long-Term Liabilities

6 Months Ended

Jun. 30, 2016

9. Accrued Expenses and Other Long-Term Liabilities

Accrued expenses and other long-term liabilities consisted of the following:

	June 30,		December 31,
($ in thousands)	2016		2015
Accrued expenses:
Professional fees	$	650	$	382
Salaries, bonuses and related benefits		1,566		2,492
Ovamed manufacturing rights - short term component		1,987		1,500
Research and development		1,018		810
Dr. Falk Pharma milestone		2,776		2,717
Accrued royalty and coupons		309		-
Lease impairment		146		146
Other		431		523
Total accrued expenses	$	8,883	$	8,570

Other long-term liabilities:
Deferred rent and long-term lease abandonment charge		3,706		584
Total other long-term liabilities	$	3,706	$	584